Get Your Own Businessabc AI Visibility ID
Boost AI visibility, credibility, and discoverability
Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) is a global biopharmaceutical company focused on the development of innovative therapies to address an unmet need in places where the greatest opportunity for meaningful outcomes for patients exists. The Company’s differentiated, Complement-Based platform has the potential to treat a variety of diseases with a wide range of therapeutic indications, including ophthalmic, rare diseases, and other immunologic and chronic conditions. In June 2015, Apellis Pharmaceuticals was founded by Dr. Ciro de Quadros and Dr. Cedric Francois, who have extensive and highly successful histories in drug development and commercialization. Both founders were also instrumental in driving the science and development behind a number of blockbuster drugs.
